Pure Global
NCT06396832

Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparing Post-Surgical Symptoms: Gastric Sleeve With and Without Omentopexy Comparison of Postoperative Symptoms: Gastric Sleeve With and Without Omentopexy.

POST-SURGICAL SYMPTOMS IN PATIENTS UNDERGOING GASTRIC SLEEVE SURGERY: OMENTOPEXY VS. NO OMENTOPEXY
Instituto Mexicano del Seguro Social·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Procedure, Unspecified
Study type
Observational
Sponsor & location
Primary sponsor
Instituto Mexicano del Seguro Social
Location
Guadalajara, Mexico
Timeline & enrollment
Phase
N/A
Start date
May 01, 2022
End date
Apr 01, 2024
Enrollment
53 participants
Primary outcome

Postoperative gastrointestinal symptoms

Summary

Metabolic surgery has proven to be an effective treatment for obesity, with laparoscopic
 sleeve gastrectomy being the most popular procedure. Omentopexy (OP) is proposed as a
 strategy to reduce associated complications. Objective was to determine the effectiveness of
 omentopexy in controlling post-surgical symptoms and to measure the need for re-intervention,
 leakage, bleeding, and mortality in patients undergoing laparoscopic sleeve gastrectomy.

ICD-10 classifications
Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06396832
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06396832 through Pure Global AI's free database. This phase not specified trial is sponsored by Instituto Mexicano del Seguro Social and is currently Completed. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 53 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.